Clinical trial
Time To Efficacy and Onset Of Action Of Linezolid
NCT00147511 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00147511 |
|---|---|
| Title | Time To Efficacy and Onset Of Action Of Linezolid |
| Official title | Time To Efficacy and Onset Of Action Of Linezolid In Skin and Soft Tissue Infections |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gram-Positive Bacterial Infections, Skin and Connective Tissue Diseases |
| Intervention type | Drug |
| Interventions | linezolid |
| Enrollment | 118 |
| Start date | Jun 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | May 10, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: